Active Shortage

DOXORUBICIN HYDROCHLORIDE INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DOXORUBICIN HYDROCHLORIDE INJECTION in Canada?

Yes. DOXORUBICIN HYDROCHLORIDE INJECTION 2MG has an active shortage reported to Health Canada (last updated July 31, 2026).

Why is DOXORUBICIN HYDROCHLORIDE INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DOXORUBICIN HYDROCHLORIDE INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file2 products · 0 same form & route

Affected strength2MG

Report last updated2026-07-31

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CAELYX

BAXTER CORPORATION

2MG · DIN 02238389

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TARO-DOXORUBICIN LIPOSOMAL

TARO PHARMACEUTICALS INC

2MG · DIN 02493020

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02409275

Strength

2MG

Dosage Form

SOLUTION

Route

INTRAVESICAL INTRAVENOUS

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-07-31

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

DOXORUBICIN HYDROCHLORIDE INJECTION has 2 shortage/discontinuation reports on file — this is one of them.

2025-12-02

Active Shortage

Disruption of the manufacture of the drug.

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163